While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of  clinicians and drug developers.

With the surge of precision medicine, scientists are increasingly in need of human biospecimens that match specific patient and specimen criteria

Anita Shah currently works at Doctor’s Data, Inc. (DDI), as that company’s elements technical manager.

Nandan Shah, director, clinical development and regulatory affairs at Regeneron Pharmaceuticals, talks to contributing editor Tanuja Koppal, PhD, about the big trends that are likely to impact informatics and data analysis in the clinical world.

Across health care and drug development, experts need advanced tools to manage specimens and their associated data

Nicholas Navin, PhD, associate professor at the MD Anderson Cancer Center, elaborates on the promise of single-cell sequencing as an innovative, noninvasive tool for research and clinical use.

Raman spectroscopy opens new approaches in clinical diagnostics for many medical conditions.

Marina Sirota, PhD, discusses trends in data analysis, tools for data storage, and tackling challenges associated with big data.

Research could pave the way to potential new treatments

New research has shown that a bacteriophage is critical to the formation of biofilms by Pseudomonas